New drug aims to ease muscle weakness in myasthenia gravis
Disease control
Recruiting now
This study tests a new drug called aritinercept in people with generalized myasthenia gravis, a condition that causes muscle weakness. The drug works by blocking two proteins that may drive the disease. Researchers want to see if it is safe and can improve daily activities. About…
Phase: PHASE1, PHASE2 • Sponsor: Aurinia Pharmaceuticals Inc. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC